FOR IMMEDIATE RELEASE

For More Information, Contact:

R. Kelly Schwalbe at 816-474-3166

Swine Industry Call for PRRS Research Proposals

Boehringer Ingelheim continues annual PRRS research program in 2010

ST. JOSEPH, Mo. (August 5, 2009) –Boehringer Ingelheim Vetmedica, Inc., August 5, 2009
(BIVI) is again seeking research study proposals focused on one of the swine
industry’s most devastating diseases -- porcine reproductive and respiratory
syndrome (PRRS). 1620 N. Woodbine Road
St. Joseph, Missouri
For the last seven years, BIVI has contributed at least $75,000 annually through 64506-2002
its Advancement in PRRS Research Awards, which fund three selected research
programs. The company’s PRRS research program is open to swine practitioners,
diagnosticians or public and private researchers in the United States, Canada and
Mexico. Selected programs are designed to investigate new ways to diagnose,
control and eradicate this costly swine disease.

Research proposals must be submitted by January 1, 2010 and awards will be

presented during the 2010 American Association of Swine Veterinarians (AASV)
Annual Meeting in Omaha. Proposals will be selected by an independent review
board based on established criteria including potential economic impact to the
swine industry, originality and scientific quality and probability of success in
completing the year-long study.

The 2009 Advancement in PRRS Research Award recipients were Jerry Torrison,
DVM, Ph.D., University of Minnesota, St. Paul, Minn.; Darwin Reickes, DVM,
Swine Vet Center, St. Peter, Minn.; Spencer Wayne, DVM, Pipestone Veterinary
Clinic, Pipestone, Minn.; and Amber Stricker, DVM, MS, Suidae Health and
Production, Algona, Iowa.
To participate in the research program, submit a proposal, cover sheet,
Curriculum Vitae and two letters of recommendation by January 1, 2010, to:
Boehringer Ingelheim Vetmedica, Inc.
Attn: Trudy Luther
“The Advanced PRRS Research Award”
5506 Corporate Dr., Suite 1600
St. Joseph, MO 64507-7752 USA

For more information and complete submission instructions, please visit us at

www.PRRSresearch.com.
Boehringer Ingelheim Vetmedica, Inc. (St. Joseph, Mo.), is a subsidiary of Boehringer
Ingelheim Corporation based in Ridgefield, Conn., and a member of the Boehringer
Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies.
Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries
and approximately 41,300 employees. Since it was founded in 1885, the family-owned
company has been committed to researching, developing, manufacturing and marketing
novel products of high therapeutic value for human and veterinary medicine.

In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while
spending approximately one-fifth of net sales in its largest business segment, Prescription
Medicines, on research and development.

For more information, please visit: www.bi-vetmedica.com.

###